Mutations in SARS-CoV-2 spike protein receptor-binding domains may yield new vaccine-resistant variants Mar 1, 2022 Predicting SARS-CoV-2 variant infectivity with biophysical principles ...

We hypothesized that mRNA vaccines encoding non-tumor antigens, including those targeting SARS-COV-2, would similarly augment responses to ICI. Methods: We utilized institutional databases to extract ...

Addressing the challenge of viral evolution As the COVID-19 pandemic has demonstrated, SARS-CoV-2 evolves rapidly, rendering many previously effective antibody treatments obsolete. Most clinical ...

Current neoantigen cancer vaccines primarily rely on dendritic cell ... Methods: We developed BSARSTNeoAgVax, a SARS-CoV-2 B cell epitope-guided neoantigen peptide or mRNA cancer nanovaccine, designed ...

The nasal vaccine, tested on animals since 2021, may offer a new tool in fighting COVID-19 with a non-invasive, ...

Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended ...

However, the ability of inactivated vaccine-induced antibodies to neutralize both SARS-CoV-2 and its Omicron variant following a third SARS-CoV-2 vaccine dose remains unclear in these patients.

Researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended, primary target. They ...

White House Website Calls SARS-CoV-2 A Virus That Originated From A Lab Leak In China ... Earlier, the website shared helpful information about vaccines, free COVID tests, and how to stay safe. But ...

A study on the post-mortem infectivity of influenza A virus (IAV), respiratory syncytial virus (RSV), and SARS-CoV-2, the virus that causes COVID ... personnel were being mobilized to help with ...